Article

Cellexus Appoints Chief Scientific Officer

Cellexus Biosystems (Cambridgeshire, UK, www.cellexusbiosystems.com) has selected Julie Bick, MD, as its chief scientific officer.

Cellexus Biosystems (Cambridgeshire, UK, www.cellexusbiosystems.com) has selected Julie Bick, MD, as its chief scientific officer. Bick has the worldwide responsibility for leading the company’s research and customer support programs and will be based in the US from the company’s wholly owned subsidiary, Cellexus Biosystems, Inc. Bick is a biochemist with considerable expertise in cell culture and has worked in the areas of protein therapeutics, protein engineering, and assay platform development. 

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
How the 15% US-EU Tariff Cap Affects Bio/pharma
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
© 2025 MJH Life Sciences

All rights reserved.